.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CX01_Glucose.Glucose .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CX01_Glucose.Glucose| name: | Glucose |
| ATC code: | B05CX01 | route: | intravenous |
| n-compartments | 1 |
Glucose is a monosaccharide sugar that serves as the main source of energy for the body's cells. It is used intravenously as a source of calories and fluid in patients unable to eat or drink, for treatment of hypoglycemia, dehydration, or during parenteral nutrition. Glucose is approved and widely used in clinical practice.
Pharmacokinetic parameters reported for healthy adult subjects after intravenous administration of glucose.
Graham, GG, et al., & Williams, KM (2011). Clinical pharmacokinetics of metformin. Clinical pharmacokinetics 50(2) 81–98. DOI:10.2165/11534750-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21241070
Alshaer, MH, et al., & Hosmann, A (2022). Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue. Antimicrobial agents and chemotherapy 66(8) e0043822–None. DOI:10.1128/aac.00438-22 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35862739
Ng, CM, et al., & De León, DD (2018). Population pharmacokinetics of exendin-(9-39) and clinical dose selection in patients with congenital hyperinsulinism. British journal of clinical pharmacology 84(3) 520–532. DOI:10.1111/bcp.13463 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29077992